These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24267872)

  • 1. Epidemiological control of drug resistance and compensatory mutation under resistance testing and second-line therapy.
    Saddler CA; Wu Y; Valckenborgh F; Tanaka MM
    Epidemics; 2013 Dec; 5(4):164-73. PubMed ID: 24267872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escaping an evolutionary lobster trap: drug resistance and compensatory mutation in a fluctuating environment.
    Tanaka MM; Valckenborgh F
    Evolution; 2011 May; 65(5):1376-87. PubMed ID: 21521192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary reversals of antibiotic resistance in experimental populations of Pseudomonas aeruginosa.
    Gifford DR; MacLean RC
    Evolution; 2013 Oct; 67(10):2973-81. PubMed ID: 24094347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens.
    Igler C; Rolff J; Regoes R
    Elife; 2021 May; 10():. PubMed ID: 34001313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermutability and compensatory adaptation in antibiotic-resistant bacteria.
    Perron GG; Hall AR; Buckling A
    Am Nat; 2010 Sep; 176(3):303-11. PubMed ID: 20624092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance.
    Blázquez J
    Clin Infect Dis; 2003 Nov; 37(9):1201-9. PubMed ID: 14557965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensation of fitness costs and reversibility of antibiotic resistance mutations.
    Schulz zur Wiesch P; Engelstädter J; Bonhoeffer S
    Antimicrob Agents Chemother; 2010 May; 54(5):2085-95. PubMed ID: 20176903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation to the cost of resistance in a haploid clonally reproducing organism: the role of mutation, migration and selection.
    Jeger MJ; Wijngaarden PJ; Hoekstra RF
    J Theor Biol; 2008 Jun; 252(4):621-32. PubMed ID: 18394653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cost of antibiotic resistance: analysis and consequences].
    Kempf I; Zeitouni S
    Pathol Biol (Paris); 2012 Apr; 60(2):e9-14. PubMed ID: 19942376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are humans increasing bacterial evolvability?
    Gillings MR; Stokes HW
    Trends Ecol Evol; 2012 Jun; 27(6):346-52. PubMed ID: 22459247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary Trajectories to Antibiotic Resistance.
    Hughes D; Andersson DI
    Annu Rev Microbiol; 2017 Sep; 71():579-596. PubMed ID: 28697667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological cost of mutational antibiotic resistance: any practical conclusions?
    Andersson DI
    Curr Opin Microbiol; 2006 Oct; 9(5):461-5. PubMed ID: 16890008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of evolutionary rescue in changing environments and the emergence of antibiotic resistance.
    Wu Y; Saddler CA; Valckenborgh F; Tanaka MM
    J Theor Biol; 2014 Jan; 340():222-31. PubMed ID: 24076261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration.
    Gould IM; MacKenzie FM
    Symp Ser Soc Appl Microbiol; 2002; (31):78S-84S. PubMed ID: 12481832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of antibiotic resistant bacteria.
    Andersson DI
    Curr Opin Microbiol; 2003 Oct; 6(5):452-6. PubMed ID: 14572536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008.
    ; ; Tapsall JW; Limnios EA; Abu Bakar HM; Darussalam B; Ping YY; Buadromo EM; Kumar P; Singh S; Lo J; Bala M; Risbud A; Deguchi T; Tanaka M; Watanabe Y; Lee K; Chong Y; Noikaseumsy S; Phouthavane T; Sam IC; Tundev O; Lwin KM; Eh PH; Goarant C; Goursaud R; Bathgate T; Brokenshire M; Latorre L; Velemu E; Carlos C; Leano S; Telan EO; Goh SS; Koh ST; Ngan C; Tan AL; Mananwatte S; Piyanoot N; Lokpichat S; Sirivongranson P; Fakahau M; Sitanilei H; Hung le V
    Commun Dis Intell Q Rep; 2010 Mar; 34(1):1-7. PubMed ID: 20521493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of mutation rates in bacteria.
    Denamur E; Matic I
    Mol Microbiol; 2006 May; 60(4):820-7. PubMed ID: 16677295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant selection window hypothesis updated.
    Drlica K; Zhao X
    Clin Infect Dis; 2007 Mar; 44(5):681-8. PubMed ID: 17278059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.